WHO MAKES THE DIABETES DRUG COPYRIGHT NO FURTHER A MYSTERY

Novo Nordisk's pricing tactics from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who's got accused the company of cost gouging, stating the stark contrast between U.S. costs and those in Europe and copyright.In Oct 2024, Novo Nordisk published a analyze on scientific journal Nature a few novel glucose-sensitive insulin N